Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
At 2.5mg/mL, 4mg equals 160 units (requiring a split injection)
Evaluation of -amino acid replacements in protein loops: effects on conformational stability and structure
Read my TrimRx review for the full breakdown
Pharmacies that prioritize sourcing from reputable suppliers may charge more, reflecting the enhanced safety and efficacy of their products
On the heels of basic research on the venom of Gila monsters in the preceding decades,1 exenatide secured the first US FDA approval in the class on April 28, 2005.2 While the prominent GLP-1 brand names are household names today, the class was off to a relatively slow start at first five years passed before it reached blockbuster status (US$1 billion (770 million) in sales), and another five went by before the first formal approval of a GLP-1 drug indicated for obesity became a reality.3 Last year saw sales for the class cross $50 billion and, with another 40% in revenue growth in store for 2025, the GLP-1 segment of the pharmaceutical industry is firmly in the rapid growth phase of the market, per Investment Bank Consensus
US$ 23.62
US$ 26.22
US$ 28.71
US$ 21.94
US$ 21.64
US$ 26.61
